Significant weight loss typically becomes visible around months 2 through 3, with the most dramatic changes occurring between months 3 and 6
Surgery also typically requires medication adjustments always handled individually by a doctor
The AACE/ACE Obesity Clinical Practice Guidelines state directly: "Obesity is a chronic, relapsing disease process" requiring treatment strategies comparable in duration to those used for hypertension or type 2 diabetes [4]
Moreover, only 28.8% of patients used semaglutide (with others on less potent medication) and less than half had obesity, meaning actual deficiency risks in real-world practice may be significantly higher
Er gehrt zu den sogenannten Dreifach-Agonisten
The growing interest in oral semaglutide, commonly referred to as oral Ozempic, reflects this desire for more convenient medication options